HSIN-FU LINTseng, Ching-YingChing-YingTsengMündel, TobyTobyMündelLin, Yi-YuanYi-YuanLinLin, Chung-ChiChung-ChiLinChen, Chiao-NanChiao-NanChenLiao, Yi-HungYi-HungLiao2022-11-242022-11-242021-09-132079-7737https://scholars.lib.ntu.edu.tw/handle/123456789/625803Adjuvant chemotherapies are commonly used for treating early-stage breast cancer. However, whether chemotherapeutic regimens affect exercise tolerance and cardiovascular responses remains unclear. Therefore, we investigated the effects of receiving CAF and AC-T on exercise tolerance and cardiovascular responses in patients with early-stage breast cancer.enAC-T; CAF; SEVR; cardiovascular responses; doxorubicin; taxanes[SDGs]SDG3journal article10.3390/biology10090910345717862-s2.0-85115268145WOS:000699454600001https://api.elsevier.com/content/abstract/scopus_id/85115268145